Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online March 9, 2007
Diabetes 56:1468-1474, 2007
DOI: 10.2337/db06-1389
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db06-1389v1
56/5/1468    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prudente, S.
Right arrow Articles by Trischitta, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prudente, S.
Right arrow Articles by Trischitta, V.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A Functional Variant of the Adipocyte Glycerol Channel Aquaporin 7 Gene Is Associated With Obesity and Related Metabolic Abnormalities

Sabrina Prudente1,2, Elisabetta Flex3, Eleonora Morini1,4, Federica Turchi1, Daria Capponi4, Salvatore De Cosmo2, Vittorio Tassi2, Valentina Guida1, Angelo Avogaro5, Franco Folli6, Francesca Maiani4, Lucia Frittitta7, Bruno Dallapiccola1,8, and Vincenzo Trischitta1,2,4

1 CSS-Mendel Institute, Rome, Italy
2 Research Laboratory of Diabetes and Endocrinology, CSS Scientific Institute, San Giovanni, Rotondo, Italy
3 Department of Cellular Biology and Neuroscience, Istituto Superiore di Sanità, Rome, Italy
4 Department of Clinical Sciences, University "La Sapienza," Rome, Italy
5 Unit of Metabolic Diseases, Department of Clinical and Experimental Medicine, University of Padua, Padua, Italy
6 Department of Medicine, Diabetes Division, University of Texas Health Science Center, San Antonio, Texas
7 Division of Endocrinology, Department of Internal and Specialist Medicine, University of Catania Medical School, Garibaldi Hospital, Catania, Italy
8 Department of Experimental Medicine and Pathology, University "La Sapienza," Rome, Italy

Address correspondence and reprint requests to Sabrina Prudente, PhD, or Vincenzo Trischitta, MD, CSS-Mendel Institute, Viale Regina Margherita 261, 00198 Rome, Italy. E-mail: s.prudente{at}css-mendel.it (S.P.) or vincenzo.trischitta{at}uniroma1.it (V.T.)

Abbreviations: AQP7, aquaporin 7; C/EBP, CCAAT/enhancer binding protein; FFA, free fatty acid; HWE, Hardy-Weinberg equilibrium; LD, linkage disequilibrium; MAF, minor allele frequency; PPAR, peroxisome proliferator–activated receptor; RXR, retinoid X receptor; SNP, single nucleotide polymorphism; UTR, untranslated region

Aquaporin 7 (AQP7), the gateway protein controlling glycerol release, has recently emerged as a modulator of adipocyte metabolism. AQP7 knockout mice develop obesity and hyperglycemia. The contribution of AQP7 to these abnormalities in humans is unknown. We examined whether common single nucleotide polymorphisms (SNPs) in the AQP7 gene modulate the risk of obesity and related abnormalities. Among several SNPs we identified, A-953G in the AQP7 promoter was associated with type 2 diabetes in 977 (530 female/447 male) Caucasians: odds ratio for XG (i.e., AG+GG) versus AA individuals was 1.36 (95% CI 1.01–1.84), P = 0.04. This finding was entirely due to the association among females (1.8 [1.2–2.6], P = 0.004), which was no longer significant when adjusted for BMI. In fact, BMI was higher in XG than in AA females (30.8 ± 6.6 vs. 28.9 ± 5.2, P = 0.002). This association was confirmed in independent case-control study (n = 299 female subjects) for morbid obesity (1.66 [1.01–2.74], P = 0.04). Luciferase and mobility shift assays showed that, compared with –953A, the –953G promoter had reduced transcriptional activity (P = 0.001) and impaired ability to bind CCAAT/enhancer binding protein (C/EBP)ß transcription factor (P = 0.01). Finally, AQP7 expression in adipose tissue decreased from AA to AG to GG individuals (P = 0.036). These data strongly suggest that AQP7 downregulation is pathogenic for obesity and/or type 2 diabetes.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
V. Ceperuelo-Mallafre, M. Miranda, M. R. Chacon, N. Vilarrasa, A. Megia, C. Gutierrez, J. M. Fernandez-Real, J. M. Gomez, E. Caubet, G. Fruhbeck, et al.
Adipose Tissue Expression of the Glycerol Channel Aquaporin-7 Gene Is Altered in Severe Obesity But Not in Type 2 Diabetes
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3640 - 3645.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. Matsumura, B. H.-J. Chang, M. Fujimiya, W. Chen, R. N. Kulkarni, Y. Eguchi, H. Kimura, H. Kojima, and L. Chan
Aquaporin 7 Is a {beta}-Cell Protein and Regulator of Intraislet Glycerol Content and Glycerol Kinase Activity, {beta}-Cell Mass, and Insulin Production and Secretion
Mol. Cell. Biol., September 1, 2007; 27(17): 6026 - 6037.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.